Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein

被引:9
|
作者
Zhang, Jun [1 ,2 ]
Tang, Weichun [3 ]
Gao, Hailong [1 ,2 ]
Lavine, Christy L. [4 ]
Shi, Wei [1 ,2 ]
Peng, Hanqin [1 ]
Zhu, Haisun [5 ]
Anand, Krishna [5 ]
Kosikova, Matina [3 ]
Kwon, Hyung Joon [3 ]
Tong, Pei [6 ,7 ]
Gautam, Avneesh [6 ,7 ]
Rits-Volloch, Sophia [1 ]
Wang, Shaowei [8 ]
Mayer, Megan L. [9 ]
Wesemann, Duane R. [6 ,7 ]
Seaman, Michael S. [4 ]
Lu, Jianming [8 ,10 ]
Xiao, Tianshu [1 ,2 ]
Xie, Hang [3 ]
Chen, Bing [1 ,2 ]
机构
[1] Boston Childrens Hosp, Div Mol Med, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
[3] United States Food & Drug Adm, Ctr Biol Evaluat & Res, Div Viral Prod, Lab Pediat & Resp Viral Dis,Off Vaccines Res & Rev, Silver Spring, MD 20993 USA
[4] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA
[5] Harvard Inst Med, Inst Prot Innovat, Boston, MA USA
[6] Brigham & Womens Hosp, Dept Med, Div Allergy & Clin Immunol, Boston, MA USA
[7] MIT & Harvard, Ragon Inst MGH, Boston, MA USA
[8] Codex BioSolut Inc, Rockville, MD USA
[9] Harvard Cryo EM Ctr Struct Biol, Boston, MA USA
[10] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA
关键词
CRYO-EM STRUCTURE; CELL ENTRY; CORONAVIRUS;
D O I
10.1038/s41594-023-01023-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Omicron subvariant BA.2 has become the dominant circulating strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in many countries. Here, we have characterized structural, functional and antigenic properties of the full-length BA.2 spike (S) protein and compared replication of the authentic virus in cell culture and an animal model with previously prevalent variants. BA.2 S can fuse membranes slightly more efficiently than Omicron BA.1, but still less efficiently than other previous variants. Both BA.1 and BA.2 viruses replicated substantially faster in animal lungs than the early G614 (B.1) strain in the absence of pre-existing immunity, possibly explaining the increased transmissibility despite their functionally compromised spikes. As in BA.1, mutations in the BA.2 S remodel its antigenic surfaces, leading to strong resistance to neutralizing antibodies. These results suggest that both immune evasion and replicative advantage may contribute to the heightened transmissibility of the Omicron subvariants. Zhang, Tang, Gao et al. report structural and functional properties of the Omicron BA.2 spike protein, and replication kinetics of the virus. Their results suggest that both immune evasion and replicative advantage may contribute to the heightened transmissibility.
引用
收藏
页码:980 / +
页数:32
相关论文
共 50 条
  • [41] SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate
    Beaudoin, Christopher A.
    Petsolari, Emmanouela
    Hamaia, Samir W.
    Hala, Sharif
    Alo, Fadwa S.
    Pandurangan, Arun P.
    Blundell, Tom L.
    Vedithi, Sundeep Chaitanya
    Huang, Christopher L. -H.
    Jackson, Antony P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 666 : 61 - 67
  • [42] Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection
    Jang, Eun Jung
    Choe, Young June
    Kim, Ryu Kyung
    Lee, Sangwon
    Park, Seon Kyeong
    Park, Young-Joon
    JAMA NETWORK OPEN, 2023, 6 (03) : E232578
  • [43] SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
    Xinling Wang
    Lu Lu
    Shibo Jiang
    Signal Transduction and Targeted Therapy, 8
  • [44] Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022
    Loconsole, Daniela
    Centrone, Francesca
    Sallustio, Anna
    Accogli, Marisa
    Casulli, Daniele
    Sacco, Davide
    Zagaria, Riccardo
    Morcavallo, Caterina
    Chironna, Maria
    VACCINES, 2022, 10 (05)
  • [45] Evolution of the SARS-CoV-2 Omicron spike
    Parsons, Ruth J.
    Acharya, Priyamvada
    CELL REPORTS, 2023, 42 (12):
  • [46] Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review
    Drysdale, Myriam
    Gibbons, Daniel C.
    Singh, Moushmi
    Rolland, Catherine
    Lavoie, Louis
    Skingsley, Andrew
    Lloyd, Emily J.
    INFECTION, 2024, 52 (01) : 1 - 17
  • [47] Clinical Characteristics and High-resolution Computed Tomography Findings of 805 Patients with Mild or Moderate Infection from SARS-CoV-2 Omicron Subvariant BA.2
    Pan, Yu-Ning
    Gu, Meng-Yin
    Mao, Quan-Liang
    Ruan, Xin-Zhong
    Du, Xian-Feng
    Gao, Xiang
    Chen, Xue-Qin
    Li, Ai-Jing
    CURRENT MEDICAL IMAGING, 2023, 20
  • [48] Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
    Xie, Ruopeng
    Edwards, Kimberly M.
    Adam, Dillon C.
    Leung, Kathy S. M.
    Tsang, Tim K.
    Gurung, Shreya
    Xiong, Weijia
    Wei, Xiaoman
    Ng, Daisy Y. M.
    Liu, Gigi Y. Z.
    Krishnan, Pavithra
    Chang, Lydia D. J.
    Cheng, Samuel M. S.
    Gu, Haogao
    Siu, Gilman K. H.
    Wu, Joseph T.
    Leung, Gabriel M.
    Peiris, Malik
    Cowling, Benjamin J.
    Poon, Leo L. M.
    Dhanasekaran, Vijaykrishna
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [49] Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids
    Hou, Yuxin
    Li, Chang
    Yoon, Chaemin
    Leung, On Wah
    You, Sikun
    Cui, Xiaoming
    Chan, Jasper Fuk-Woo
    Pei, Duanqing
    Cheung, Hoi Hung
    Chu, Hin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [50] Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai
    Zhang, Juanjuan
    Tan, Suoyi
    Peng, Cheng
    Xu, Xiangyanyu
    Wang, Mengning
    Lu, Wanying
    Wu, Yanpeng
    Sai, Bin
    Cai, Mengsi
    Kummer, Allisandra G.
    Chen, Zhiyuan
    Zou, Junyi
    Li, Wenxin
    Zheng, Wen
    Liang, Yuxia
    Zhao, Yuchen
    Vespignani, Alessandro
    Ajelli, Marco
    Lu, Xin
    Yu, Hongjie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (42)